A New IPO Market Urged

Schachter, Ken
November 2008
Red Herring;11/21/2008, p2
Trade Publication
The article discusses results of the study entitled "Why Are IPOs in the ICU?," conducted by David Weild and Edward Kim. In the study, auditing and consultancy firm GrantThornton calls for a new government-regulated Second Market open to all investors that would let developing companies raise capital. The study says that efforts to create credible alternatives to an initial public offering have centered on private placement markets, such as the Nasdaq Portal Alliance and Goldman Sachs Tradable Unregistered Equities.


Related Articles

  • Grant Thornton looks to book $35M. C.M.O. // Private Placement Letter;11/25/2002, Vol. 20 Issue 46, p2 

    Reports that accounting firm Grant Thornton LP entered the private placement market in the week of November 25, 2002.

  • Grant Thornton, Nasdaq seminar on IPOs.  // Long Island Business News (7/1993 to 5/2009);9/02/96, Vol. 43 Issue 36, p16 

    Reports that Grant Thornton LLP will co-sponsor a seminar on initial public offering (IPO) on the Nasdaq Stock Market titled `The ABC's of Going Public' at the Huntington Hilton in Long Island, New York on September 19, 1996. Topics to be discussed; Contact information.

  • Grant Thornton accounts for $35 million via BMO Nesbitt Burns. E. H. // Private Placement Letter;12/16/2002, Vol. 20 Issue 49, p1 

    Reports that Grant Thornton has opened a 35 million dollar package from the private buyside via BMO Nesbitt Burns Inc. Terms of the private placement.

  • Grant Thornton Finds $10M For MTN Program. Roper, Akil Salim // Private Placement Letter;03/22/99, Vol. 17 Issue 12, p3 

    Reports that Nesbit Burns tacked in private placement funds for Grant Thornton International as part of the company's medium-term note program. Maturity year of the offering; Information on Nesbit Burns; Sales of Grant in 1997.

  • Genesis Research & Development.  // New Zealand Management;Dec2001, Vol. 48 Issue 11, p29 

    Provides information on the biotechnology company Genesis Research & Development. Information on genomics; Treatment developed by the company for psoriasis; Amount of private placements raised by the company from institutional investors; Amount raised by Genesis through an initial public...

  • How to be first in line for an IPO.  // Medical Economics;07/10/2000, Vol. 77 Issue 13, p56 

    Focuses on the use of private placements as a tool to purchase stocks during a company's initial public offering in the United States. Disadvantages of private placements; Need to maintain investments for at least two years; Need for knowledge of the company's investments in other businesses.

  • Private offerings can offer benefits to emerging growth...  // Orange County Business Journal;11/10/97, Vol. 20 Issue 45, p38 

    Details the benefits of private offerings in raising capital for the emerging growth of a company. Comparison of initial public offering (IPO) to a private offering or placement; Factors to be considered between public and private offering; Differences between operating a privately held company...

  • PPL 50.  // Private Placement Letter;05/24/99, Vol. 17 Issue 21, p6 

    Presents a list of traditional private placements from several issuers. Senior notes from Allied Capital Corp.; Asset backed securities from Industrial Bank of Korea; Medium term notes from Grant Thornton International.

  • PPL 50.  // Private Placement Letter;06/14/99, Vol. 17 Issue 24, p9 

    Presents information on several circled traditional private placements offering by different companies in the United States (US), based on the filings of the US Securities and Exchange Commission. Grant Thornton International; Henry Schein Inc.; Lord Corp.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics